Thirty and Ninety Day Outcomes after Sublobar Resection with and without brachytherapy for Non-small cell lung cancer: Results from a Multicenter Phase III study

INTRODUCTION: Sublobar resection (SR) is commonly used for patients considered high-risk for lobectomy. Non-operative therapies are increasingly being reported for similar risk patients because of perceived lower morbidity. We report 30 and 90 day adverse events (AEs) from ACOSOG Z4032; a multicente...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Fernando, Hiran C, Landreneau, Rodney J, Mandrekar, Sumithra J, Hillman, Shauna L, Nichols, Francis C, Meyers, Bryan, DiPetrillo, Thomas A, Heron, Dwight E, Jones, David R, Daly, Benedict D T, Starnes, Sandra L, Tan, Angelina, Putnam, Joe B
Format: Artigo
Langue:Inglês
Publié: 2011
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3199353/
https://ncbi.nlm.nih.gov/pubmed/21872277
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtcvs.2011.07.051
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires